1. Home/
  2. Compounds/
  3. tanespimycin:bortezomib (250:1 mol/mol)

tanespimycin:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tanespimycin:bortezomib (250:1 mol/mol)
PharmacoGx tanespimycin:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tanespimycin:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ZER1 CTRPv2 pan-cancer AAC -0.17 9e-06
mRNA PYURF CTRPv2 pan-cancer AAC 0.17 9e-06
mRNA RABIF CTRPv2 pan-cancer AAC 0.17 9e-06
mRNA EXOSC8 CTRPv2 pan-cancer AAC 0.18 1e-05
mRNA LAMA5 CTRPv2 pan-cancer AAC -0.19 1e-05
mRNA PRIMPOL CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA CREBRF CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA LTV1 CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA PIGY CTRPv2 pan-cancer AAC 0.16 2e-05
mRNA DTL CTRPv2 pan-cancer AAC 0.17 2e-05
Download CSV